Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Orexo’s OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC

· OX640 is Orexo’s nasal epinephrine powder product for the acute treatment of severe allergic reactions including anaphylaxis, based on the company´s proprietary drug delivery platform, AmorphOX® · The American Academy of Allergy, Asthma & Immunology (AAAAI) is the largest professional medical organization in the United States devoted to the allergy/immunology specialty · The AAAAI program committee selected OX640 to be presented at its late breaking oral abstract session.   Uppsala, Sweden – February 6, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the

Transaction in Own Shares

    6 February 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |05/02/2024|+-----------------------------------------------------------

Notice to attend the Extraordinary General Meeting of Sivers Semiconductors AB (publ)

The shareholders of Sivers Semiconductors AB (publ) (the “Company”), reg. no. 556383-9348, are hereby invited to attend the Extraordinary General Meeting to be held on Wednesday, 28 February 2024 at 4.00 pm at the Company’s premises at Torshamnsgatan 48 in Kista, Sweden.Notification to attend etc. Shareholders who wish to attend the Extraordinary General Meeting must · be recorded in the share register kept by Euroclear Sweden AB no later than on Tuesday, 20 February 2024; and · notify the Company their intention to participate no later than Thursday, 22 February 2024, via mail

Lagercrantz interim report 1 April - 31 December 2023

Third quarter (1 OcTOBER – 31 DECEMBER 2023) · Net revenue increased by 6% to MSEK 2,054 (1,941), where the acquired growth was 7% and the organic growth was minus 2%. · Operating profit (EBITA) increased by 9% to MSEK 353 (323), equivalent to an EBITA margin of 17.2% (16.6). · Profit after financial items (EBT) increased by 13% to MSEK 284 (251). · Profit after taxes increased by 13% to MSEK 225 (199).  NIne Months (1 april – 31 DECEMBER 2023) · Net revenue increased by 15% to MSEK 5,970 (5,206), where the acquired growth was 11% and the organic growth was 0.5%. ·

Bravida awarded SEK 183 million installation project for cleaner wastewater at Stockholm’s new treatment plant

Bravida has been awarded the task by Veidekke of carrying out installation work for heating and plumbing, support systems and HVAC during the expansion of the Henriksdal wastewater treatment plant to create a larger facility in Sickla outside Stockholm. The new treatment plant will help make the water discharged into the Baltic Sea cleaner.Part of the Stockholm Future Wastewater Treatment (SFA) project involves developing the Henriksdal wastewater treatment plant and the Sickla facility to create one of the most modern plants in the world, at which wastewater is treated with new efficient

Invitation to presentation of Catena Media’s Q4 results 2023

Catena Media’s year-end report for the fourth quarter ended 31 December 2023 will be published in English on Tuesday 13 February at 07:00 CET. Following the report’s release, a combined presentation webcast and teleconference including a question-and-answer session will be held at 09:00 CET on the same day, hosted by CEO Michael Daly and Interim Group CFO Erik Edeen. WebcastVia the webcast you can ask written questions. If you wish to participate via webcast, please use the following link:https://ir.financialhearings.com/catena-media-q4-2023 Teleconference Via the

Wihlborgs’ 2023 year-end report will be presented on 13 February

On Tuesday 13 February, at 7:30 a.m. (CET), Wihlborgs’ 2023 year-end report will be published. Wihlborgs invites press, investors and analysts to a webcast and telephone conference at 9:00 a.m. (CET) on the same date.During the webcast and telephone conference, Ulrika Hallengren, CEO of Wihlborgs, and Arvid Liepe, CFO, will present Wihlborgs’ 2023 year-end report. Following the presentation, there will be the opportunity to pose questions. The presentation will be held in English.  Date:                  13 February Time:                  The report will be published at 7:30 a.m. (CET)

Investment Outlook: Investors look past soft landing

Our main thesis for 2024 is that positive drivers, a gradual decline in interest rates and a bottoming out of the economy will lay the groundwork for a broader stock market upturn, driven by former stragglers. But the economic soft-landing scenario is already largely discounted in the market, which limits its potential. Nevertheless, we recommend staying on the positive side with regard to risk assets, i.e. between neutral and overweight. “Our strategy since September 2022 has been to avoid being too defensively positioned and to ensure that our portfolios have good risk diversification.

Alfa Laval AB (publ) Fourth quarter and full year 2023

Highlights · Order intake increased by 7 percent to SEK 16.9 (15.8) billion. · Net sales increased by 8 percent to SEK 17.8 (16.5) billion. · Adjusted EBITA increased by 12 percent to SEK 2.8 (2.5) billion, corresponding to a margin of 15.9 (15.3) percent. · Strong cash flow from operating activities of SEK 3.9 (1.7) billion. · Earnings per share of SEK 3.77 (3.00).Summary Fourth quarter Order intake increased by 7 percent* at SEK 16,920 (15,767) million.Net sales increased by 7 percent* to SEK 17,839 (16,484) million. Adjusted EBITA**: SEK 2,830 (2,520) million.

BlueNord: Preliminary Production for January 2024

Oslo, 6 February 2024: BlueNord ASA ("BlueNord" or the "Company") has today announced its preliminary production figures for January 2024. The Company had a preliminary production in January of net 23.5 mboepd. The production during the month was in line with expectations across all the producing hubs and with an overall preliminary operational efficiency of 90%. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act and requirements under the EU Market Abuse Regulation. *** Contact:Cathrine Torgersen, Chief

Key information relating to the proposed cash dividend by Multiconsult ASA

Multiconsult ASA (OSE: MULTI) The board of directors will propose a dividend of NOK 8.00 per share for the financial year 2023 to the annual general meeting on 11 April 2024. Dividend amount: NOK 8.00 per shareDeclared currency: NOKLast day including right: 11 April 2024Ex-date: 12 April 2024Record date: 15 April 2024Payment date: On or around 22 April 2024Date of approval: 11 April 2024The dividend payment is conditioned upon approval by general meeting in the company, summoned to be held on 11 April 2024.See further information about the background for the dividend

Multiconsult fourth quarter and full year 2023 – a good end to the year

Multiconsult ASA (OSE: MULTI) Multiconsult ended the year with a good quarter. The performance was influenced by high activity, increased capacity through organic growth, and overall good operational performance throughout the year. Net operating revenues grew by 20.8 per cent to NOK 1 361.5 million in the quarter, and by 14.6 per cent to NOK 4 802.5 million for the year. The robust organic revenue growth observed has continued and came in at 16.1 per cent for the quarter. EBITA for the full year came in at NOK 419.5 million (408.5), while EBITA adjusted for one-offs was NOK 446.2 million, a

Slättö acquires residential portfolio with a focus on sustainable investments

Slättö continues to expand its portfolio with the acquisition of twelve residential properties in central Norrkoping, a growing university city in Sweden.A fund managed by Slättö has completed the acquisition of 325 apartments from Eklöf Fastigheter, representing a combined leasable area of almost 24,000 square meters. - This is our first residential acquisition in almost two years. Since early 2022, we have seen increased yield requirements in the segment. Our overall conviction towards residential has always been strong, however, the current combination of rental growth potential and

OssDsign AB (publ) publishes year-end report 2023

Exceptional sales growth for OssDsign Catalyst confirms the value of our strategy shiftOssDsign AB (publ) announces that the interim report for Q4 2023 is now available as a PDF on the company’s website www.ossdsign.com/reports. A PDF version is also attached to this press release.   The Q4 2023 results will also be presented at an investor webcast today February 6th at 10:00 CET. The webcast can be accessed via the following link: https://www.finwire.tv/webcast/ossdsign/ossdsign-year-end-report-2023/ 

BerGenBio ASA: Invitation to fourth quarter 2023 results webcast

Bergen, Norway, 6 February 2024 - BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, will announce its results for the fourth quarter 2023 on Wednesday 14 February 2024. BerGenBio's senior management team will provide a business update at 10:00 am CET. The presentation will webcast live. To participate in the webcast please register in the following link:   BerGenBio Q4 2023 webcast registration link 

Swedavia’s traffic statistics for January 2024

During January, Swedavia's ten airports served nearly 2.1 million passengers, which is on a par with the number of passengers in January of last year. The trend of stronger demand for international travel, especially to Europe, and weaker demand for domestic travel continued in January, which is one of the weakest travel months of the year. Stockholm Arlanda Airport and Göteborg Landvetter Airport had the highest growth, while Kiruna Airport was the regional airport with the highest growth."In January, demand for air travel was stable, despite uncertainties such as the global situation,

Sales of Leqembi® totaled 1.1 billion yen in the fourth quarter 2023

Stockholm, Sweden, February 6, 2024 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today issued their quarterly report containing Leqembi sales for the fourth quarter 2023 (third quarter of Eisai’s fiscal year, ending March 2024). In total, sales of JPY 1.1 billion were recorded in the period, resulting in a royalty to BioArctic amounting to SEK 7.3 million.Eisai serves as the lead of Leqembi development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority. BioArctic

Nordea Bank Abp: Repurchase of own shares on 05.02.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares05.02.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 05.02.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+---------+-------------------+-------------------+| Trading |Number of| Weighted average |Total cost, EUR* **||venue (MIC| shares |price / share, EUR*| || Code) | | ** | |+----------+---------+-------------------+-------------------+|XHEL |620,664 |10.74

Proposal by the Shareholders´ Nomination Board for the composition and remuneration of the Board of Directors of Teleste Corporation

Teleste CorporationStock exchange releaseFebruary 5, 2024 at 20:00  PROPOSAL BY THE SHAREHOLDERS’ NOMINATION BOARD FOR THE COMPOSITION AND REMUNERATION OF THE BOARD OF DIRECTORS OF TELESTE CORPORATION Shareholders’ Nomination Board The General Meeting of Shareholders of Teleste Corporation (“Teleste”), held on April 22, 2020, decided, by proposal of Teleste’s Board of Directors, to set up a Shareholders’ Nomination Board for the purpose of preparing proposals on the election and remuneration of the members of the Board of Directors to the Annual General Meeting and for

Correction: Systemair changes Group management

Pressmeddelande 5 February 2024 Systemair AB (NASDAQ OMX Stockholm: SYSR) changes Group management.    Systemair continues its expansion phase with a focus on profitability and increased growth. From 5 February, Ulrika Hellman becomes the new Vice President M&A with responsibility for acquisitions, company integration and business development and a member of Systemair's Group Management. Ulrika replaces Janni Weber who left in 2023.   Ulrika comes from ASSA Abloy Global Solutions as Head of M&A and Business Development and has previously worked at AddLife, Sandvik Materials

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 05 February 2024 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 05 February 2024 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Buy-back of shares in Arise during week 5, 2024

During the period between 29 January and 2 February 2024 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 85,941 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 100 million, which Arise announced on 14 November 2023. The share repurchase program, which runs from 16 November 2023 until the date of Arise's Annual General Meeting

There are no items matching the current filter
There are no more items matching the current filter
Back to top